E-LIB Suche - Ergebnisse für: Chang, John Wen‐Cheng

1

Gut microbiota and clinical response to immune checkpoint i..:

Chang, John Wen-Cheng ; Hsieh, Jia-Juan ; Tsai, Chih-Yu...
Biomedical Journal. , 2024

Link: https://doi.org/10.1016/..

2

Distinct changes to pancreatic volume rather than pancreati..:

Wei, Hung-Hui ; Lai, Ying-Chieh ; Lin, Gigin...
Diabetology & Metabolic Syndrome. 16 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Real-world evidence of lorlatinib therapy in Taiwanese pati..:

Shih, Jin-Yuan ; Luo, Yung-Hung ; Chang, Gee-Chen...
Journal of the Formosan Medical Association. 123 (2024) 8 - p. 875-881 , 2024

Link: https://doi.org/10.1016/..

4

Clinical characteristics and genetic HLA marker for patient..:

Hsu, Hung-Chih ; Chung, Wen-Hung ; Lin, Yung-Chang...
Allergology International. , 2024

Link: https://doi.org/10.1016/..

5

Effectiveness and safety of afatinib, gefitinib, and erloti..:

Hung, Ling-Jen ; Hsu, Ping-Chih ; Yang, Cheng-Ta...
Aging. , 2024

Link: https://doi.org/10.18632..

6

Comprehensive assessment of pretreatment sarcopenia impacts..:

Wu, Chen‐Te ; Hsu, Ping‐Chih ; Chang, John Wen‐Cheng...
Thoracic Cancer. 14 (2023) 25 - p. 2548-2557 , 2023

Link: https://doi.org/10.1111/..

7

Genomic and tumour microenvironmental biomarkers of immune ..:

Chang, John Wen‐Cheng ; Huang, Chien‐Jung ; Huang, Wen‐Kuan...
Clinical & Translational Immunology. 12 (2023) 8 - p. , 2023

Link: https://doi.org/10.1002/..

8

Personalized neoantigen-based T cell therapy triggers cytot..:

Hung, Shuen-Iu ; Chu, Mu-Tzu ; Hou, Ming-Mo...
Biomedicine & Pharmacotherapy. 169 (2023) - p. 115928 , 2023

Link: https://doi.org/10.1016/..

9

Epidermal growth factor receptor tyrosine kinase inhibitors..:

Chang, John Wen‐Cheng ; Huang, Chen‐Yang ; Fang, Yueh‐Fu...
Thoracic Cancer. 14 (2022) 1 - p. 12-23 , 2022

Link: https://doi.org/10.1111/..

10

Radiation Recall Pneumonitis: A Rare Syndrome That Should B..:

Jan, Pei-Rung ; Chang, John Wen-Cheng ; Wu, Chiao-En
Cancers. 14 (2022) 19 - p. 4642 , 2022

Link: https://doi.org/10.3390/..

11

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mu..:

Chang, John Wen-Cheng ; Huang, Chen-Yang ; Fang, Yueh-Fu...
Cancers. 14 (2022) 4 - p. 977 , 2022

Link: https://doi.org/10.3390/..

12

Sequential treatment in advanced non–small cell lung cancer..:

Hsu, Ping-Chih ; Chang, John Wen-Cheng ; Chang, Ching-Fu...
Therapeutic Advances in Respiratory Disease. 16 (2022) - p. 175346662211327 , 2022

Link: https://doi.org/10.1177/..

13

Safety of Tepotinib Challenge after Capmatinib-Induced Pneu..:

Tseng, Liang-Wei ; Chang, John Wen-Cheng ; Wu, Chiao-En
International Journal of Molecular Sciences. 23 (2022) 19 - p. 11809 , 2022

Link: https://doi.org/10.3390/..

14

Epidermal growth factor receptor tyrosine kinase inhibitors..:

Chang, John Wen‐Cheng ; Huang, Chen‐Yang ; Fang, Yueh‐Fu...
Thoracic Cancer. 13 (2022) 13 - p. 1888-1897 , 2022

Link: https://doi.org/10.1111/..

15

The survival after discontinuation of EGFR‐TKIs due to into..:

Chang, John Wen‐Cheng ; Chang, Ching‐Fu ; Huang, Chen‐Yang...
Thoracic Cancer. 14 (2022) 4 - p. 348-356 , 2022

Link: https://doi.org/10.1111/..